Email Updates

You are here

Home

15 MARCH 2019 VOLUME 20 ISSUE 10

Media Coverage

  • Nigeria’s HIV/AIDS Prevalence Rate Drops to 1.4 Percent

    With 1.9 million persons now living with HIV/AIDS in Nigeria, the world’s largest black nation has dropped to fourth position in global HIV prevalence rate, a new survey suggests.

    March 15, 2019
    General
    Punch Nigeria

  • Israeli Government Donates Gadgets for Non Surgical Male Circumcision to the Ministry of Health

    Receiving the donation at Ndeke House yesterday, Health Minister of the Republic of Zambia, Hon. Dr. Chitalu Chilufya stated that the gesture from the Israeli government had come at the correct time when the government was racing to meet its target of circumcising two million men and boys in a bid to achieve epidemic control of HIV/AIDS by 2020.

    March 14, 2019
    Voluntary Medical Male Circumcision
    Lusaka Times

  • TAF: Quick-dissolve Combination PrEP Insert Is Effective Against HIV Infections in Monkeys; Intermittent Solo Pill Less So

    Two studies in monkeys of experimental pre-exposure prophylaxis (PrEP) regimens featuring the drug tenofovir alafenamide (TAF) produced differing results when presented at last week’s CROI conference. As a third study suggested, the results may partly be due to the way TAF is absorbed into cells.

    March 13, 2019
    PrEP
    aidsmap

  • The Genetic Mutation Behind the Only Apparent Cure for HIV

    The news last week that a second patient may have been cured of HIV using a bone marrow transplant from a donor with known HIV resistance has brought new attention to a gene mutation that many researchers believe is key to ending the epidemic.

    March 13, 2019
    Cure
    The BodyPro

  • Trump’s Proposed Budget Undermines His HIV Plan, Experts Say

    President Trump’s 2020 budget request of an extra $291 million to fight the spread of HIV, experts said on Tuesday, will not be remotely sufficient to meet the goal he announced in his State of the Union address: to nearly eliminate the AIDS epidemic in the United States within 10 years.

    March 12, 2019
    General
    New York Times

  • Sadiq Khan: Cash Row Is Denying Londoners Access to HIV ‘Wonder Drug’

    Mr. Khan intervened in a battle between London councils and the Government over the estimated £3 million cost of extending a trial providing free PrEP, a daily pre-exposure prophylaxis pill that protects against the AIDS virus.

    March 12, 2019
    PrEP
    Evening Standard

  • Remembering the Activists Who Helped Make HIV/AIDS Research Possible

    In the first decade of the epidemic, when AIDS was invariably lethal, panic and ignorance were rife even among medical professionals. Those afflicted were met with moral judgment instead of sympathy. Politicians were unhurried about — or downright hostile to — funding research to combat HIV/AIDS. It took years of struggle by militant AIDS activists before mindless prejudice about those with the disease would cease and progress could be made toward a cure.

    March 12, 2019
    General
    Washington Post

  • ‘Gentler Cure’ Technique Produces Delay in Viral Rebound in Some People Taken off HIV Therapy

    Researchers have introduced genetic changes into human T-cells that make them virtually immune to HIV infection, and the viral load in HIV-positive people who are inoculated with these cells returns more slowly when they are taken off therapy, the recent Conference on Retroviruses and Opportunistic Infections (CROI 2019) heard.

    March 12, 2019
    Cure
    aidsmap

  • This HIV Pill Saves Lives. So Why Is It so Hard to Get in the Deep South?

    Even in a tiny town in the Mississippi Delta, Robert Rowland, an openly gay, single, middle-aged man, has no problem finding sex partners. What he can’t find is PrEP, the once-a-day pill that protects users against HIV infection, or a doctor who knows much about it, or a drugstore that stocks it.

    March 11, 2019
    PrEP
    Washington Post

  • Largest Ever HIV Prevention Study Delivers Sobering Message

    The recipe for ending HIV epidemics seems straightforward. Introduce widespread testing. Immediately put those who test positive on antiretroviral (ARV) drugs, which suppress the virus to undetectable levels so those people won’t infect others. The number of new infections will drop, and the epidemic will peter out.

    March 11, 2019
    Treatment
    Science Magazine

  • Young Black Men at Risk for HIV Underestimate Threat

    A study that started out looking at HIV risk behaviors and substance use turned into an opportunity for researchers to examine what it would take for young black men who have sex with men to try pre-exposure prophylaxis (PrEP) and stay on it.

    March 11, 2019
    PrEP
    Medscape

  • Youth Uses Sport to Preach Voluntary Circumcision

    A young man is combining his love for sport and activism to raise awareness on Voluntary Male Medical Circumcision (VMMC) in the Kavango East and West regions.

    March 11, 2019
    Voluntary Medical Male Circumcision
    New Era

  • National Women and Girls HIV/AIDS Awareness Day: Let’s Talk about PrEP

    Across the country, unless you’re a gay man, the chances that you’ve even heard about PrEP are slim. And with Black women being diagnosed with HIV at a rate 16 times higher than white women in America, the way that PrEP is currently marketed is problematic.

    March 10, 2019
    PrEP
    Essence

  • This is Not A Cure for My HIV

    HIV is not going away anytime soon. I’ve been living with it for more than 20 years and have seen the overhyped stories promising a cure around the corner pop up regularly, particularly around the time of big AIDS conferences. The news last week that a second person seems to have gone into long-term remission from HIV after a stem cell transplant is a real scientific advance. But I fear the sensationalism with which this report was received could do more harm than good. It obscures the actual struggles we face in combating this epidemic.

    March 9, 2019
    Cure
    New York Times

  • Bit by Bit, Scientists Gain Ground on AIDS

    The unnamed “London patient” — the second person apparently cured of HIV — earned all the headlines. But other research released this week at the Conference on Retroviruses and Opportunistic Infections showed that scientists are making slow but steady progress on the tactics and medicines needed to fight the epidemic, especially in Africa.

    March 8, 2019
    PrEP, Treatment
    New York Times

  • TAF as Effective as TDF in Cisgender Women, with Fewer Side Effects

    Initial data gathered from seven separate studies found tenofovir alafenamide (TAF) is just as effective as tenofovir disoproxil fumarate (Viread, TDF), with fewer side effects to the kidneys and bones, when used in cisgender women. These results, presented this week at the Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle, are similar to those found in cisgender men.

    March 8, 2019
    PrEP
    The BodyPro

  • Men, the HIV Prevention Pill Just Got Easier. Get the '2-1-1' on What to Know

    Gay men can now confidently take the HIV prevention pill before and for two days after sex — instead of daily doses — without compromising their protection against the virus, Anova senior clinical specialist Kevin Rebe says.

    February 25, 2019
    PrEP
    Bhekisisa

Published Research

Announcements